147 related articles for article (PubMed ID: 8577939)
1. Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells.
Kask K; Berthold M; Bourne J; Andell S; Langel U; Bartfai T
Regul Pept; 1995 Nov; 59(3):341-8. PubMed ID: 8577939
[TBL] [Abstract][Full Text] [Related]
2. The human galanin receptor: ligand-binding and functional characteristics in the Bowes melanoma cell line.
Heuillet E; Bouaiche Z; Ménager J; Dugay P; Munoz N; Dubois H; Amiranoff B; Crespo A; Lavayre J; Blanchard JC
Eur J Pharmacol; 1994 Oct; 269(2):139-47. PubMed ID: 7531645
[TBL] [Abstract][Full Text] [Related]
3. Characterization of galanin receptors in the insulin-secreting cell line Rin m 5F: evidence for coupling with a pertussis toxin-sensitive guanosine triphosphate regulatory protein.
Lagny-Pourmir I; Amiranoff B; Lorinet AM; Tatemoto K; Laburthe M
Endocrinology; 1989 May; 124(5):2635-41. PubMed ID: 2468476
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine release.
Ogren SO; Pramanik A; Land T; Langel U
Eur J Pharmacol; 1993 Sep; 242(1):59-64. PubMed ID: 7693496
[TBL] [Abstract][Full Text] [Related]
5. A clonal rat pancreatic delta cell line (Rin14B) expresses a high number of galanin receptors negatively coupled to a pertussis-toxin-sensitive cAMP-production pathway.
Amiranoff B; Lorinet AM; Laburthe M
Eur J Biochem; 1991 Jan; 195(2):459-63. PubMed ID: 1847683
[TBL] [Abstract][Full Text] [Related]
6. The galanin antagonist M35 has intrinsic agonistic activity in the dorsal root ganglion.
Mahoney SA; Hosking R; Wynick D
Neuroreport; 2003 Aug; 14(12):1649-52. PubMed ID: 14502094
[TBL] [Abstract][Full Text] [Related]
7. Galanin receptor and its ligands in the rat hippocampus.
Fisone G; Langel U; Carlquist M; Bergman T; Consolo S; Hökfelt T; Undén A; Andell S; Bartfai T
Eur J Biochem; 1989 Apr; 181(1):269-76. PubMed ID: 2469577
[TBL] [Abstract][Full Text] [Related]
8. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes.
Bartfai T; Langel U; Bedecs K; Andell S; Land T; Gregersen S; Ahrén B; Girotti P; Consolo S; Corwin R
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11287-91. PubMed ID: 7504301
[TBL] [Abstract][Full Text] [Related]
9. Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35.
Gregersen S; Lindskog S; Land T; Langel U; Bartfai T; Ahrén B
Eur J Pharmacol; 1993 Feb; 232(1):35-9. PubMed ID: 7681407
[TBL] [Abstract][Full Text] [Related]
10. Possible evidence for endogenous production of a novel galanin-like peptide.
Wang ZL; Kulkarni RN; Wang RM; Smith DM; Ghatei MA; Byfield PG; Bennet WM; Bloom SR
J Clin Invest; 1997 Jul; 100(1):189-96. PubMed ID: 9202071
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a role of the neuropeptide galanin in spatial learning.
Ogren SO; Hökfelt T; Kask K; Langel U; Bartfai T
Neuroscience; 1992 Nov; 51(1):1-5. PubMed ID: 1281521
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of galanin-inhibited insulin release. Occurrence of a pertussis-toxin-sensitive inhibition of adenylate cyclase.
Amiranoff B; Lorinet AM; Lagny-Pourmir I; Laburthe M
Eur J Biochem; 1988 Oct; 177(1):147-52. PubMed ID: 2460348
[TBL] [Abstract][Full Text] [Related]
13. Effects of putative galanin antagonists M35 and C7 on rat exocrine pancreas.
Kisfalvi I; Rácz G; Bálint A; Máté M; Oláh A; Zelles T; Vizi ES; Varga G
J Physiol Paris; 2001; 95(1-6):385-9. PubMed ID: 11595464
[TBL] [Abstract][Full Text] [Related]
14. Characterization of galanin receptor in canine small intestinal circular muscle synaptosomes.
Chen CK; McDonald TJ; Daniel EE
Am J Physiol; 1994 Jan; 266(1 Pt 1):G106-12. PubMed ID: 7508196
[TBL] [Abstract][Full Text] [Related]
15. Galanin receptor in the rat pancreatic beta cell line Rin m 5F. Molecular characterization by chemical cross-linking.
Amiranoff B; Lorinet AM; Laburthe M
J Biol Chem; 1989 Dec; 264(34):20714-7. PubMed ID: 2479648
[TBL] [Abstract][Full Text] [Related]
16. New high affinity peptide antagonists to the spinal galanin receptor.
Xu XJ; Wiesenfeld-Hallin Z; Langel U; Bedecs K; Bartfai T
Br J Pharmacol; 1995 Oct; 116(3):2076-80. PubMed ID: 8640348
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of adenylate cyclase activity by galanin in rat insulinoma cells is mediated by the G-protein Gi3.
de Mazancourt P; Goldsmith PK; Weinstein LS
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):369-75. PubMed ID: 7526840
[TBL] [Abstract][Full Text] [Related]
18. Galanin receptors in a hamster pancreatic beta-cell tumor: identification and molecular characterization.
Amiranoff B; Servin AL; Rouyer-Fessard C; Couvineau A; Tatemoto K; Laburthe M
Endocrinology; 1987 Jul; 121(1):284-9. PubMed ID: 2439312
[TBL] [Abstract][Full Text] [Related]
19. Galanin-(1-16) modulates 5-HT1A receptors in the ventral limbic cortex of the rat.
Díaz-Cabiale Z; Narváez JA; Finnman UB; Bellido I; Ogren SO; Fuxe K
Neuroreport; 2000 Feb; 11(3):515-9. PubMed ID: 10718306
[TBL] [Abstract][Full Text] [Related]
20. Effect of M35, a neuropeptide galanin antagonist on glucose uptake translated by glucose transporter 4 in trained rat skeletal muscle.
Jiang L; Shi M; Guo L; He B; Li G; Zhang L; Zhang L; Shao H
Neurosci Lett; 2009 Dec; 467(2):178-81. PubMed ID: 19835935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
